No Data
No Data
Express News | HC Wainwright & Co. Reiterates Neutral on Panbela Therapeutics
H.C. Wainwright Maintains Panbela Therapeutics(PBLA.US) With Hold Rating
H.C. Wainwright analyst Joseph Pantginis maintains $Panbela Therapeutics(PBLA.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 35.6% and a total average return of
Express News | Panbela Therapeutics Inc: Enrollment Positions Co for Enrollment Completion by Q1 2025
Express News | Panbela Therapeutics Inc: Interim Survival Analysis Still Expected Early 2025
Express News | Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 Aspire Clinical Trial Dsmb Recommended Continuation With No Trial Modification
Panbela Therapeutics at Risk: Penny Stock Classification May Weaken Legal Safeguards and Hurt Valuation
No Data